Crinetics Pharmaceuticals, Inc. · NASDAQ:CRNX

Dapice Joshua J. reported a 8.50% stake in Crinetics Pharmaceuticals, Inc. (Schedule 13G/A)

Event Dec 31, 2025 · Filed Feb 5, 2026

Dapice Joshua J. reported a 8.50% stake in Crinetics Pharmaceuticals, Inc., 8,024,098 shares, as a passive investor on Dec 31, 2025. Filed Feb 5, 2026 (Schedule 13G/A).

Stake
8.50%
Shares
8,024,098
Intent
Passive
What changed
Stake changed
Filed together
31 holders

The filing in full

HolderStakeShares
Farallon Capital Partners, L.P.0.60%584,527
Farallon Capital Institutional Partners, L.P.0.70%709,270
Farallon Capital Institutional Partners II, L.P.0.20%168,850
Farallon Capital Institutional Partners III, L.P.0.10%103,335
Four Crossings Institutional Partners V, L.P.0.10%135,338
Farallon Capital Offshore Investors II, L.P.1.40%1,369,733
Farallon Capital (AM) Investors, L.P.0.10%72,967
Farallon Capital F5 Master I, L.P.0.20%197,760
Farallon Healthcare Partners Master, L.P.4.90%4,682,318
Farallon Partners, L.L.C.8.20%7,826,338
Farallon Institutional (GP) V, L.L.C.0.10%135,338
Farallon F5 (GP), L.L.C.0.20%197,760
Farallon Healthcare Partners (GP), L.L.C.4.90%4,682,318
Dapice Joshua J.8.50%8,024,098
Dreyfuss, Philip D.8.50%8,024,098
Dunn Hannah E.8.50%8,024,098
Fried, Richard B0%0
Gehani, Varun N.8.50%8,024,098
Giauque, Nicolas8.50%8,024,098
Husen, Avner A.8.50%8,024,098
Kim, David T.8.50%8,024,098
Linn, Michael G.8.50%8,024,098
Luo Patrick (Cheng)8.50%8,024,098
Patel, Rajiv A.0%0
Roberts, Jr., Thomas G.8.50%8,024,098
Saito Edric C.8.50%8,024,098
Seybold, William0%0
Short Daniel S.8.50%8,024,098
Spokes, Andrew J. M.8.50%8,024,098
Warren, John R.8.50%8,024,098
Wehrly, Mark C.8.50%8,024,098

Source

View original at SEC

Related